Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Niraparib-abiraterone-prednisone combo improves multiple outcomes in HRR+ mCRPC
In patients with metastatic castration-resistant prostate cancer (mCRPC) with homologous recombination repair (HRR) gene alterations*, combining niraparib with abiraterone acetate plus prednisone (AAP) in the first-line setting improved radiographic progression-free survival (rPFS) and other outcomes, results of the phase III MAGNITUDE study showed.
Niraparib-abiraterone-prednisone combo improves multiple outcomes in HRR+ mCRPC
04 Mar 2022
Empiric antibiotic use confers no therapeutic benefit in COVID-19 pneumonia
The use of empiric antibiotic therapy appears to prevent neither deterioration nor death among patients with COVID-19 pneumonia, as shown in a Singapore study.
Empiric antibiotic use confers no therapeutic benefit in COVID-19 pneumonia
04 Mar 2022
Ustekinumab safe, effective in Asians with severe plaque psoriasis
Ustekinumab, a human monoclonal antibody that binds to the p40 subunit of both interleukin (IL)-12 and IL-23, demonstrates effectiveness and safety in the treatment of multiethnic Asian patients with moderate to severe plaque psoriasis, according to a Singapore study.
Ustekinumab safe, effective in Asians with severe plaque psoriasis
04 Mar 2022
Minor changes in glucose levels first week after COVID-19 vaccine
Patients with type 1 diabetes mellitus (T1DM) may experience a temporary change in their blood glucose levels in the first week following COVID-19 vaccination, according to a small English study.
